Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy

2019 ◽  
Vol 179 (1) ◽  
pp. 11-23 ◽  
Author(s):  
Clémence Pinard ◽  
Marc Debled ◽  
Houda Ben Rejeb ◽  
Valérie Velasco ◽  
Christine Tunon de Lara ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Residual Cancer ◽  
Cancer Burden ◽  
Residual Cancer Burden ◽  
Tumor Infiltrating Lymphocyte

Residual cancer burden and neoangiogenesis after neoadjuvant chemotherapy in triple-negative breast cancer

The Breast ◽  
2017 ◽  
Vol 32 ◽  
pp. S100-S101
Author(s):  
M. Miyashita ◽  
H. Sasano ◽  
K. Tamaki ◽  
H. Hirakawa ◽  
T. Ishida ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Residual Cancer ◽  
Cancer Burden ◽  
Residual Cancer Burden

Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival

2020 ◽  
Vol 122 (8) ◽  
pp. 1761-1769
Author(s):  
Thomas L. Sutton ◽  
Alexander Schlitt ◽  
Stuart K. Gardiner ◽  
Nathalie Johnson ◽  
Jennifer R. Garreau
Keyword(s):  
Breast Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Residual Cancer ◽  
Cancer Burden ◽  
Residual Cancer Burden ◽  
Time To Surgery
Sign in / Sign up

Export Citation Format

Share Document